182 related articles for article (PubMed ID: 9463635)
1. Changes in collagen phenotypes during progression and regression of cardiac hypertrophy.
Yang CM; Kandaswamy V; Young D; Sen S
Cardiovasc Res; 1997 Nov; 36(2):236-45. PubMed ID: 9463635
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme inhibitor, captopril, inhibits cardiac hypertrophy without changing collagen types and concentration in spontaneously hypertensive rats.
Kuzuo H; Honda M; Ishinaga Y; Morioka S; Tanaka K; Kuramochi T; Mansoor AM; Yamori Y; Moriyama K
Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):253-60. PubMed ID: 8485925
[TBL] [Abstract][Full Text] [Related]
3. Alteration of cardiac collagen phenotypes in hypertensive hypertrophy: role of blood pressure.
Mukherjee D; Sen S
J Mol Cell Cardiol; 1993 Feb; 25(2):185-96. PubMed ID: 8474126
[TBL] [Abstract][Full Text] [Related]
4. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
Brilla CG; Matsubara L; Weber KT
Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
[TBL] [Abstract][Full Text] [Related]
5. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B
Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325
[TBL] [Abstract][Full Text] [Related]
6. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats.
Mukherjee D; Sen S
Circ Res; 1990 Dec; 67(6):1474-80. PubMed ID: 2147130
[TBL] [Abstract][Full Text] [Related]
7. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
Brilla CG; Janicki JS; Weber KT
Circulation; 1991 May; 83(5):1771-9. PubMed ID: 1850668
[TBL] [Abstract][Full Text] [Related]
8. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats.
Brooks WW; Bing OH; Conrad CH; O'Neill L; Crow MT; Lakatta EG; Dostal DE; Baker KM; Boluyt MO
Hypertension; 1997 Dec; 30(6):1362-8. PubMed ID: 9403554
[TBL] [Abstract][Full Text] [Related]
9. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats.
Norton GR; Tsotetsi J; Trifunovic B; Hartford C; Candy GP; Woodiwiss AJ
Circulation; 1997 Sep; 96(6):1991-8. PubMed ID: 9323091
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat.
Brooks WW; Bing OH; Robinson KG; Slawsky MT; Chaletsky DM; Conrad CH
Circulation; 1997 Dec; 96(11):4002-10. PubMed ID: 9403625
[TBL] [Abstract][Full Text] [Related]
11. Normal left ventricular diastolic compliance after regression of hypertrophy.
Schraeger JA; Canby CA; Rongish BJ; Kawai M; Tomanek RJ
J Cardiovasc Pharmacol; 1994 Mar; 23(3):349-57. PubMed ID: 7515976
[TBL] [Abstract][Full Text] [Related]
12. Changes in contractile protein gene expression with ageing and with captopril-induced regression of hypertrophy in the spontaneously hypertensive rats.
Dalton GR; Jones JV; Levi AJ; Levy A
J Hypertens; 2000 Sep; 18(9):1297-306. PubMed ID: 10994761
[TBL] [Abstract][Full Text] [Related]
13. Diverse effects of Ace inhibitors and angiotensin II receptor antagonists on prevention of cardiac hypertrophy and collagen distribution in spontaneously hypertensive rats.
Gagnon C; Legault F; Geraldes P; Tanguay JF; Lambert C
Int J Cardiol; 2004 Dec; 97(3):373-81. PubMed ID: 15561321
[TBL] [Abstract][Full Text] [Related]
14. Localization of alpha1(I) collagen mRNA in myocardium from the spontaneously hypertensive rat during the transition from compensated hypertrophy to failure.
Bing OH; Ngo HQ; Humphries DE; Robinson KG; Lucey EC; Carver W; Brooks WW; Conrad CH; Hayes JA; Goldstein RH
J Mol Cell Cardiol; 1997 Sep; 29(9):2335-44. PubMed ID: 9299357
[TBL] [Abstract][Full Text] [Related]
15. Altered signal transduction system in hypertrophied myocardium: angiotensin II stimulates collagen synthesis in hypertrophied hearts.
Kawaguchi H; Kitabatake A
J Card Fail; 1996 Dec; 2(4 Suppl):S13-9. PubMed ID: 8951556
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxymatrine, the active component from Radix Sophorae flavescentis (Kushen), on ventricular remodeling in spontaneously hypertensive rats.
Huang XY; Chen CX
Phytomedicine; 2013 Feb; 20(3-4):202-12. PubMed ID: 23211799
[TBL] [Abstract][Full Text] [Related]
17. Wall stress-induced arrhythmias in the working rat heart as left ventricular hypertrophy regresses during captopril treatment.
Dalton GR; Jones JV; Evans SJ; Levi AJ
Cardiovasc Res; 1997 Mar; 33(3):561-72. PubMed ID: 9093526
[TBL] [Abstract][Full Text] [Related]
18. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
[TBL] [Abstract][Full Text] [Related]
19. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
Makino N; Sugano M; Ohtsuka S; Sawada S; Hata T
Cardiovasc Res; 1999 Dec; 44(3):543-8. PubMed ID: 10690286
[TBL] [Abstract][Full Text] [Related]
20. Altered inotropic responsiveness and gene expression of hypertrophied myocardium with captopril.
Brooks WW; Bing OH; Boluyt MO; Malhotra A; Morgan JP; Satoh N; Colucci WS; Conrad CH
Hypertension; 2000 Jun; 35(6):1203-9. PubMed ID: 10856264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
